Internal Reference Number: FOI_6584
Date Request Received: 11/05/2022 00:00:00
Date Request Replied To: 24/05/2022 00:00:00
This response was sent via: By Email
Request Summary: Intra-vitreal injections or implants
Request Category: Companies
| Question Number 1: I am analysing the usage of intra-vitreal injections or implants by the ¾¨Ó㴫ý. I would greatly appreciate if you could answer the following questions: How many of the following intra-vitreal injections/implants has your trust administered in the four-month period from January to April 2022: • Aflibercept • Bevacizumab • Brolucizumab • Dexamethasone • Fluocinolone acetonide • Ranibizumab | |
| Answer To Question 1: Aflibercept 1657 Bevacizumab 9 Brolucizumab 0 Dexamethasone 14 Fluocinolone Acetonide <5 Ranibizumab 47 | |
| Question Number 2: Please provide the number of injections/implants by eye condition for the four-month period from January to April 2022. Eye Conditions - Wet Age-Related Macular Degeneration wAMD Aflibercept Bevacizumab Brolucizumab Dexamethasone Fluocinolone acetonide Ranibizumab | |
| Answer To Question 2: Aflibercept 1164 Bevacizumab 6 Brolucizumab 0 Dexamethasone 0 Fluocinolone Acetonide 0 Ranibizumab 43 | |
| Question Number 3: Please provide the number of injections/implants by eye condition for the four-month period from January to April 2022. Eye Condition - Diabetic Macular Degeneration DMO Aflibercept Bevacizumab Brolucizumab Dexamethasone Fluocinolone acetonide Ranibizumab | |
| Answer To Question 3: Aflibercept 190 Bevacizumab 0 Brolucizumab 0 Dexamethasone 9 Fluocinolone Acetonide <5 Ranibizumab 0 | |
| Question Number 4: Please provide the number of injections/implants by eye condition for the four-month period from January to April 2022. Eye Conditions - Retinal Vein Occulusion RVO Aflibercept Bevacizumab Brolucizumab Dexamethasone Fluocinolone acetonide Ranibizumab | |
| Answer To Question 4: Aflibercept 236 Bevacizumab 0 Brolucizumab 0 Dexamethasone <5 Fluocinolone Acetonide 0 Ranibizumab <5 | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¾¨Ó㴫ý Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
